期刊文献+

双氢青蒿素对肿瘤细胞及肿瘤动物模型的抑制作用 被引量:14

The inhibitory effects of dihydroartennuin on tumor cell and animal remove neoplasia model
下载PDF
导出
摘要 目的:观察双氢青蒿素对多种肿瘤细胞和动物移植瘤模型的抑制作用,分析其抗癌作用的特异性。方法:用MTT法、SRB法观察和比较双氢青蒿素对多种肿瘤细胞和正常人体细胞的抑制作用,采用小鼠的B16-BL6、H22和Lewis等肿瘤模型分析双氢青蒿素对肿瘤生长的抑制作用以及铁对双氢青蒿素抗肿瘤效应的药物协同作用。结果:双氢青蒿素对小鼠的B16-BL6、H22和Lewis肿瘤模型的肿瘤生长有较强的抑制作用;提前6h口服少量硫酸亚铁,可明显增强双氢青蒿素对B16-BL6、H22的抗肿瘤效应;双氢青蒿素对K562、KB、HCT、SGC7901、Hela、HepG、BGC823、KCC853、Bel7402、A549、B16-BL6细胞均有抑制作用。IC50(μg/mL)分别为4.12、10.21、11.02、11.77、13.03、18.36、26.47、28.02、44.55、46.28、54.46。在17.5~35μg/mL药物浓度作用下,正常细胞(HELF)有3%~5%生长,而肿瘤细胞没有增长,并有部分死亡。结论:双氢青蒿素对多种肿瘤细胞和动物移植瘤模型具有一定的选择性抑制作用,铁剂有抗癌协同作用。 Objective To obseverve the inhibitory effects of dihydroartennnin on tumor cell and animal neoplasia model. Methods Inhibition effects of dihydroarteannuin on muhi-tumors and normal cells were observed by method of MTT, SRB and animal remove neoplasia model, respectively. The synergistic action of dihydroarteannuin and ferrum on anti-tumors was studied. Results The inhibitive effects of dihydroarteannuin on B16-BL6, H22 and Lewis remove neoplasia model were stronger. Anti-tumor effects of dihydroarteannuin were increasing when mice were taken orally in advance 6 h. Dihydroarteannuin inhibited K562, KB, HCT, SC, C7901, Hela, HepG, B GC823, KCC 853, Be17402, A549, B 16-BL6 cells. IC50 were 4. 12, 10.21,11.02,11.77,13.03,18.36,26. 47,28.02,44. 55,46. 28,54 and 46 μg/mL. Within 17.5 μg/mL to 35 μg/mL concentration, common cells increased 3% ~ 5% , and tumor cells did not and died partly. Conclusion dihydroar-teannuin kills tumor cells and animal remove neoplasia mode specificly, which has synergistic action of anti-tumors with ferrum.
出处 《实用医学杂志》 CAS 2006年第24期2835-2837,共3页 The Journal of Practical Medicine
关键词 青蒿素 肿瘤 实验性 抗肿瘤药 Artemisinin Neoplasms, experimental Antineoplasfie agents
  • 相关文献

参考文献16

  • 1孙玮辰,韩家娴.四种青蒿酸及青蒿B衍生物的体外抗癌作用[J].中国药理学报,1992,13(6):541-543. 被引量:39
  • 2WOERDENBAG H J, MOSKAL T A, PRAS N, et al. Cytotoxicity of artmisnin-related endoperioxidees to Ehrlich ascites tumor cells [J]. J Nat Prod, 1993, 56(6): 849.
  • 3LAI H, SINGH N P. Selsective cancer cells cytotoxiclty from exposure to dihydroartemiasnin and holotransferrin [J]. Cancer Lett, 1995,91(1):41.
  • 4杨小平,潘启超,梁永钜,张以琳.青蒿酯钠的抗肿瘤作用[J].癌症,1997,16(3):186-187. 被引量:57
  • 5张星,杨小平,潘启超.青蒿酯钠抗人肝癌(BEL-7402)与诱导凋亡[J].中草药,1998,29(7):467-469. 被引量:39
  • 6McLEAN W G, WARD S A. In vitro neurotoxicity of artemlsinin derivatives [J]. Med Trop(Mars), 1998,58(3): 28 - 31.
  • 7MUKANGANYAMA S, WIDERSTEN M. Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing antlcancer drug resistance [J]. Cancer, 2002, 97(5):700 - 705.
  • 8REUNGPATTHANAPHONG P, MANKHETKORN S. Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines [J]. Biol Pharm Bull,2002,25(12): 1555 - 1561.
  • 9SADAVA D, PHILLIPS T, LIN C, et al, Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells[J]. Cancer Lett,2002,179(2): 151 - 156.
  • 10李英.青蒿素药物的研究进展[M].北京:科学出版社,1999:90—98.

二级参考文献41

共引文献175

同被引文献120

引证文献14

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部